snowdeal.org > {bio,medical}informatics

{bio,medical} informatics

Friday, November 09, 2001

bookmark: connotea :: del.icio.us ::digg ::furl ::reddit ::yahoo::

National Post Online Compaq Canada reaches deal to distribute genome database

"Celera Genomics, the first company to successfully sequence the human genome, announced a deal with Compaq Canada Corp. yesterday that will give Canadian non-profit researchers access to its genomic database."

""This is the first time we've entered into an agreement where the computing environment and the data will go hand in hand," said Dr. Craig Venter, president of Celera and one of world's foremost genome researchers. "There's been interest in giving Canada access to this information for some time, it just hasn't been possible to get it together.""

GenomeWeb Celera, Compaq Pen Deal to Provide Canadian Academia With Cheap Access to Data
"Academic research contracts for access to this system have been priced around $15,000, said Lewis, but under the new arrangement the price will fall to around $8,000. He estimated that Celera, based in Rockville, Md., holds fewer than 25 contracts with Canadian academic organizations.

“It allows smaller universities to access our products without a lot of hassles,” Lewis added in an interview. “There’s been some really good work in the Maritime provinces, for example, but they are small universities. This will make it as easy for them as it is for large universities.”"

redux [06.26.01]
Forbes IBM's Biotech Resurgence
"In 1998, biotech upstart Celera Genomics needed a supercomputer to help it map the human genome. It didn't turn to IBM , which built 204 of the 500 fastest supercomputers. Both Celera and its academic competition, the Human Genome Project, used machines built by Compaq Computer. Two years later, Compaq is the leading seller of supercomputers to biological researchers.

But IBM noticed that biologists now need microprocessors as much as microscopes. A year ago, it used $100 million to start a division that sells computers, software and services to biotechnology and drug companies. This life sciences division has had some success; pulling into second place behind Compaq, it must do better."

redux [08.14.01]
Business 2.0 6,160,717,289 Cures for Cancer
"For years, technologists have dreamed that information technology and biotechnology would someday converge into one seamless superscience that could crack the molecular code of disease and yield a gold mine of new treatments and cures. It always seemed so logical, even if it never quite seemed to happen. Some very big names in tech -- Bill Gates ( MSFT ), Paul Allen, and Jim Clark, among others -- for years have been placing bets on so-called convergence companies that promised to exploit the merging of computing and biotech. Allen alone has investments in more than 50 of them, mostly obscure companies that use words like "genomics," "bioinformatics," and "proteomics" to describe what they do. This industry is so new it hasn't settled on a single name yet."

"Now, like a middle-age actor who has just been discovered, convergence has hit the big time. Corporate giants such as IBM ( IBM ) and Compaq ( CPQ ) are pouring $100 million dollops of cash into "life science" projects that mesh computers and biotech."

[ rhetoric ]

“Bioinformatics will be at the core of biology in the 21st century. In fields ranging from structural biology to genomics to biomedical imaging, ready access to data and analytical tools are fundamentally changing the way investigators in the life sciences conduct research and approach problems. Complex, computationally intensive biological problems are now being addressed and promise to significantly advance our understanding of biology and medicine. No biological discipline will be unaffected by these technological breakthroughs.”

BIOINFORMATICS IN THE 21st CENTURY

[ search ]

[ outbound ]

{bio,medical} informatics

[ rhetoric ]

[ search ]

[ outbound ]

[ schwag ]

[ et cetera ]